DHA

Docosahexaenoic acid

High-quality DHA for compliant and consistent infant formula formulation

Docosahexaenoic acid (DHA) is a long-chain polyunsaturated omega-3 fatty acid naturally present in human milk and widely used in infant formula. As part of balanced lipid strategies alongside arachidonic acid (ARA), DHA can contribute to responsible early life nutrition formulation.

In the European Union, DHA is a mandatory component of infant formula. Current legislation requires infant formula to contain 20–50 mg DHA per 100 kcal, reflecting its recognized role in early life nutrition.

For infant formula manufacturers, this regulatory framework places particular importance on ingredient quality, consistency and documentation.

DHA in early life nutrition

Human milk naturally contains both DHA and ARA, two long-chain polyunsaturated fatty acids that play important roles during infancy. These fatty acids are incorporated into infant formula to help reflect the lipid composition of human milk.

Because endogenous synthesis of DHA in infants is limited, dietary supply through breast milk or formula is an important source during early development.

Scientific research continues to evaluate how DHA levels and DHA-to-ARA balance influence early life nutrition strategies. For manufacturers, this ongoing research highlights the importance of formulation precision and stable fatty-acid composition.

Consistency you can rely on

Infant formula requires clearly defined ingredient specifications and regulatory alignment. Our DHA solutions support:

• High purity and consistent fatty-acid composition
• Comprehensive documentation and traceability
• Alignment with European regulatory requirements
• Reliable long-term supply continuity

By combining strict quality standards with technical expertise, we support manufacturers in maintaining stable and compliant formulations.

Aligned with ongoing scientific research

Research in early life nutrition continues to examine DHA and ARA supplementation strategies, particularly in sensitive populations such as preterm infants. These studies reflect an evolving scientific landscape in which lipid composition and fatty-acid balance remain active areas of investigation.

For formulators, this underscores the importance of dependable ingredients that enable predictable DHA levels and consistent fatty-acid ratios.

Supporting responsible infant nutrition

At Vaneeghen, we connect science-backed ingredients with manufacturers across Europe. Our approach to DHA combines quality assurance, transparency and collaborative technical support to help bring safe, consistent and compliant infant nutrition products to market.

Explore our Insights article to learn more about recent clinical research on DHA and ARA strategies in early life nutrition.

Related lipid ingredients for infant nutrition

Docosahexaenoic acid (DHA) is often formulated alongside arachidonic acid (ARA) as part of balanced lipid strategies in early life nutrition. Learn more about our ARA solutions and recent European research on DHA and ARA strategies.

→ Arachidonic Acid (ARA)
→ Insight: Recent European research on DHA and ARA